Vascular Stents Market is set to grow at a 6.65% CAGR, reaching USD 18.28 billion by 2032, analyses DelveInsight

According to DelveInsight's assessment, the rising global burden of cancer is significantly increasing the demand for advanced treatment approaches such as tumor ablation. Minimally invasive ablation techniques are gaining strong traction due to their advantages, including faster recovery times, lower complication risks, and reduced costs compared with traditional surgical procedures. At the same time, continuous improvements in ablation technologies - particularly in radiofrequency, microwave, and cryoablation systems - have enhanced treatment accuracy, safety, and overall outcomes, making these solutions increasingly preferred by clinicians and patients alike.

DelveInsight's report, "Vascular Stents Market Insights, Competitive Landscape and Market Forecast-2032," delivers an in-depth evaluation of the current market scenario, future outlook, technological advancements, key growth drivers, market barriers, and the competitive environment. It also highlights the major pipeline products and leading players actively shaping the vascular stents landscape.

Learn why North America continues to dominate the Vascular Stents market: Vascular Stents Market Trends - https://www.delveinsight.com/sample-request/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Vascular Stents Overview
Vascular stents are small, expandable mesh-like tubes designed to keep narrowed or blocked blood vessels open and maintain proper blood circulation. These devices are commonly inserted into arteries or veins affected by disorders such as atherosclerosis or peripheral artery disease. Delivered via catheter and expanded inside the vessel, stents help reinforce the vessel walls.
They are available in several types - bare-metal stents, drug-eluting stents (DES) coated with medications to prevent restenosis, and bioabsorbable stents that degrade over time. These devices play a critical role in managing coronary artery disease, carotid artery disease, and various other vascular conditions.

DelveInsight Vascular Stents Market Analysis
DelveInsight estimates that the global vascular stents market was valued at USD 11,232.93 million in 2024 and is expected to grow at a CAGR of 6.35% from 2025 to 2032, ultimately reaching USD 18,277.68 million by 2032.

Vascular Stents Market Insights
North America is anticipated to command the largest share of the vascular stents market in 2024. The region's leadership is supported by a high incidence of cardiovascular diseases, strong healthcare infrastructure, and the presence of prominent MedTech companies. Moreover, favorable reimbursement structures, rising healthcare spending, and rapid uptake of technologically advanced stent systems further strengthen the region's position.

Explore key highlights in the Vascular Stents Market Insights report: https://www.delveinsight.com/sample-request/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Recent Developments in the Vascular Stents Market
• June 2024: Royal Philips announced the first implantation of the Duo Venous Stent System after receiving FDA PMA approval. The device treats symptomatic venous outflow obstruction in patients with chronic venous insufficiency (CVI).
• January 2024: W. L. Gore & Associates received FDA approval for a lower-profile GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft).
• January 2024: Reflow Medical, Inc. secured CE Mark certification in the EU for the Bare Temporary Spur Stent System, intended for infrapopliteal lesions when used with a drug-coated balloon to enhance drug uptake.
These technological advancements and regulatory milestones are expected to fuel robust growth in the vascular stents market over the forecast period.

Key Companies Active in the Vascular Stents Market
Major Vascular Stents companies operating in the global vascular stents space include Medtronic, Abbott, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, eucatech AG, MicroPort Scientific Corporation, Meril Life Sciences, Vascular Concepts (SMT), W. L. Gore & Associates, Becton Dickinson, ENDOLOGIX LLC, Biosensors International, Lombard Medical, Translumina GmbH, JOTEC GmbH, iVascular, Cordis, Cook Medical, SCITECH, and several others.

Discover which MedTech innovators are emerging as market trendsetters: https://www.delveinsight.com/sample-request/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Vascular Stents Market Landscape Analysis
Continuous improvements in polymer materials, stent architecture, and drug-delivery technologies have significantly boosted the performance and safety profile of drug-eluting stents. Leading manufacturers are actively developing advanced DES platforms offering greater biocompatibility and bioresorbability.

For instance, in August 2022, Medtronic introduced the Onyx FrontierTM drug-eluting stent following CE Mark approval. Building upon the success of the Resolute OnyxTM DES, this next-generation stent offers an enhanced delivery system for greater precision and improved outcomes in complex procedures.
These advancements are expected to accelerate the adoption of vascular stents globally and strengthen market growth.

Vascular Stents Market Report Scope
• Coverage: Global
Study Timeline: 2022-2032
• Segmentation
- By Product Type: Coronary Stents, Peripheral Stents (Carotid, Iliac, Femoral, Others), EVAR Stent Grafts (AAA and TAA stents)
- By Type: Bare-Metal Stents, Drug-Eluting Stents
- By Material: Metal, Polymer
- By Delivery Mode: Balloon-Expandable, Self-Expandable Stents
- By End-User: Hospitals, Ambulatory Surgical Centers
- By Geography: North America, Europe, Asia-Pacific, Rest of the World
- The report also includes detailed company profiles, case studies, analyst insights, expert (KOL) opinions, and Porter's Five Forces Analysis.

Get a quick breakdown of how the vascular stents market is expected to evolve by 2032: https://www.delveinsight.com/sample-request/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.